Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Medical Distribution

Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Revenue projections:

Revenue projections for CAH
Revenue projections for CAH

With Cardinal Health, Inc.'s revenue forecasted to drop below last year's level, investors are expected to take a cautious stance. Such declines typically affect a company's bottom line, reducing profitability and making investors hesitant to invest heavily in the company until financial performance improves.

Financial Ratios:

currentRatio 0.907000
forwardPE 18.742777
debtToEquity 0.000000
earningsGrowth -0.195000
revenueGrowth 0.110000
grossMargins 0.037550
operatingMargins 0.014130
trailingEps 6.480000
forwardEps 12.044640

CAH's Forward PE ratio is favorable, meaning the stock price aligns well with earnings and isn't overvalued. This allows room for growth, making it an attractive investment for those seeking potential upside while ensuring the stock is not overpriced.
Cardinal Health, Inc.'s low earnings and revenue growth suggest that the company may see declining profits. This indicates potential financial challenges ahead, and could lead to a more cautious outlook from investors.
Cardinal Health, Inc.'s negative gross and operating margins point to financial difficulties, as the company is incurring losses at both the production and operational levels. This suggests a potential decline in profitability and raises concerns about its financial outlook.
Cardinal Health, Inc.'s forward EPS being higher than its trailing EPS suggests that the company is expected to generate stronger profits this year. This points to improving financial performance, with Cardinal Health, Inc. anticipated to deliver better earnings than it did in the prior year.

Price projections:

Price projections for CAH
Price projections for CAH

Cardinal Health, Inc.'s price projections have gradually risen, indicating growing confidence in the company's prospects. This upward trend suggests that analysts expect Cardinal Health, Inc. to continue performing well in the future.

Insider Transactions:

Insider Transactions for CAH
Insider Transactions for CAH


Cardinal Health, Inc. experienced 5 sell transactions with market price of 196.502001953125 per share.No sell transactions were carried out during the period under review.More buys than sells near the current price levels of CAH might signal a favorable outlook for the stock. Investors seem to be showing confidence by purchasing more, potentially expecting positive future performance.

Recommendation changes over time:

Recommendations trend for CAH
Recommendations trend for CAH


CAH has been receiving a buy bias from analysts, indicating confidence in its investment potential. This could drive more investors to view CAH as a reliable choice for their money, offering a promising avenue for future growth and financial gains.